Citation: Jf. Tomera et Af. Kaul, REGIONAL THROMBOLYTIC INFUSION FOR PERIPHERAL ARTERIAL-OCCLUSION AND DEEP-VEIN THROMBOSIS - TRIED AND TRUE, American journal of health-system pharmacy, 54(17), 1997, pp. 1988-1991
Citation: Af. Kaul et Jf. Tomera, CRITERIA FOR USE OF REGIONAL UROKINASE INFUSION FOR PERIPHERAL ARTERIAL-OCCLUSION, American journal of health-system pharmacy, 54(17), 1997, pp. 2000-2001
Citation: Af. Kaul et Jf. Tomera, CRITERIA FOR USE OF REGIONAL UROKINASE INFUSION FOR DEEP-VEIN THROMBOSIS, American journal of health-system pharmacy, 54(17), 1997, pp. 2002-2003
Authors:
BRAMLET DA
KING H
YOUNG L
WITT JR
STOUKIDES CA
KAUL AF
Citation: Da. Bramlet et al., MANAGEMENT OF HYPERCHOLESTEROLEMIA - PRACTICE PATTERNS FOR PRIMARY-CARE PROVIDERS AND CARDIOLOGISTS, The American journal of cardiology, 80(8B), 1997, pp. 39-44
Authors:
BRAMLET DA
KING HM
WITT JR
BOSCH RJ
KAUL AF
Citation: Da. Bramlet et al., CHOLESTEROL MANAGEMENT BY INTERVENTIONAL AND INVASIVE CARDIOLOGISTS -RESULTS FROM A QA AUDIT IN PATIENTS WITH CORONARY HEART-DISEASE, The American journal of cardiology, 80, 1997, pp. 241-241
Authors:
AFORISMO JF
KAUL AF
TOMONDY PA
PARRY GE
STAUBACH LB
REGALLI G
DINE AP
Citation: Jf. Aforismo et al., FLUOROQUINOLONE USE FOR ACUTE CYSTITIS IN AN IPA-MODEL MANAGED CARE ORGANIZATION, American journal of health-system pharmacy, 52(23), 1995, pp. 2702-2704
Citation: Af. Kaul, PHARMACOECONOMIC CONSIDERATIONS IN PERIPHERAL ARTERIAL THROMBOLYTIC THERAPY, Journal of vascular and interventional radiology, 6(6), 1995, pp. 104-110
Citation: Af. Kaul, MEDICAL OUTCOMES MANAGEMENT AND COST-BENEFIT CONSIDERATIONS - AN OVERVIEW, Investigative radiology, 29, 1994, pp. 190000059-190000063